TOMBOLINI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.325
EU - Europa 698
AS - Asia 625
SA - Sud America 129
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 2.801
Nazione #
US - Stati Uniti d'America 1.295
SG - Singapore 337
RU - Federazione Russa 187
IE - Irlanda 170
BR - Brasile 116
CN - Cina 115
DE - Germania 95
VN - Vietnam 62
SE - Svezia 57
IT - Italia 44
HK - Hong Kong 40
GB - Regno Unito 34
UA - Ucraina 25
FI - Finlandia 24
CA - Canada 22
TR - Turchia 18
FR - Francia 15
BE - Belgio 13
ES - Italia 12
IN - India 12
ZA - Sudafrica 11
AR - Argentina 7
BD - Bangladesh 6
CZ - Repubblica Ceca 6
IQ - Iraq 6
JP - Giappone 6
MX - Messico 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
AU - Australia 3
EU - Europa 3
LT - Lituania 3
NL - Olanda 3
PH - Filippine 3
PK - Pakistan 3
ID - Indonesia 2
MA - Marocco 2
UY - Uruguay 2
UZ - Uzbekistan 2
AT - Austria 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
ET - Etiopia 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.801
Città #
Chandler 192
Singapore 181
Dublin 170
Dallas 164
San Jose 117
Ashburn 109
Jacksonville 95
Santa Clara 51
Ann Arbor 45
Hong Kong 40
New York 38
Munich 37
The Dalles 35
Boardman 32
Los Angeles 23
Beijing 22
Wilmington 21
Lawrence 20
Princeton 20
Hanoi 19
Moscow 18
Ho Chi Minh City 17
Bremen 15
São Paulo 15
Brussels 13
Columbus 13
Orem 13
Nanjing 12
Council Bluffs 11
Helsinki 11
Izmir 10
Rome 8
Stockholm 8
Woodbridge 8
Johannesburg 7
Turku 7
Brno 6
Brooklyn 6
Changsha 6
Frankfurt am Main 6
Haiphong 6
L'aquila 6
Manchester 6
San Mateo 6
Seattle 6
Shenyang 6
Atlanta 5
Chennai 5
Des Moines 5
Falls Church 5
Grafing 5
Houston 5
Kunming 5
Lappeenranta 5
Montreal 5
Tokyo 5
Warsaw 5
Belo Horizonte 4
Berlin 4
Denver 4
Falkenstein 4
Milan 4
Mountain View 4
Nanchang 4
Phoenix 4
Poplar 4
Shanghai 4
Toronto 4
Washington 4
Boston 3
Da Nang 3
Guangzhou 3
Lauterbourg 3
Madrid 3
Mexico City 3
Mumbai 3
Norwalk 3
Ottawa 3
San Francisco 3
Ankara 2
Baghdad 2
Cape Town 2
Charlotte 2
Chicago 2
Curitiba 2
Dearborn 2
Düsseldorf 2
Guarulhos 2
Hanover 2
Hebei 2
Hefei 2
Lanzhou 2
London 2
L’Aquila 2
Montevideo 2
New Delhi 2
Redwood City 2
Ribeirão Preto 2
Salvador 2
Santo André 2
Totale 1.852
Nome #
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 200
Moderate hypofractionation in patients with low-risk prostate cancer: Long-term outcomes 177
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 165
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 154
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 145
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 143
New approaches in glioblastoma multiforme: The potential role of immune-check point inhibitors 142
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 136
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 133
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 130
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 130
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 128
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 125
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 124
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 124
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 124
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 124
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 122
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 109
Sinonasal Undifferentiated Carcinoma in a Patient Previously Treated for an Intestinal-Type Adenocarcinoma: Metachronous Neoplasms or Recurrence of a Different Tumor Type? 89
Resilience in Radiotherapy Services During the COVID-19 Emergency: Collaboration Between the Regional Radiation Oncology Departments of Lazio, Abruzzo and Molise 65
Targeted molecular therapy in glioblastoma 51
Totale 2.840
Categoria #
all - tutte 10.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 8 25 5
2021/2022144 7 1 29 9 3 9 7 7 18 6 8 40
2022/2023491 30 42 6 80 33 52 0 24 200 6 12 6
2023/2024138 6 14 11 5 6 60 9 2 0 5 6 14
2024/2025629 18 10 30 60 89 69 82 48 115 19 50 39
2025/20261.094 69 88 150 160 143 68 154 25 81 156 0 0
Totale 2.840